Lehi, Utah - June 3rd, 2025 - CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body's immune system to fight cancer, today announced that ...

The chip maker's chief executive reiterated confidence in the strength of AI-driven semiconductor demand. How Moderna Went From Pandemic Hero to Vaccine Victim The biotech's mRNA vaccines were lauded ...

The federal government should be investing and working to expand the nation’s scientific and public health arsenal, not ...

Walt Disney is laying off several hundred people globally across multiple divisions, including marketing for film and television, TV publicity, casting and development, and corporate financial ...

Bristol-Myers Squibb Company (NYSE:BMY), which focuses on innovative cancer and immunology treatments, is a leader in the ...

Northwestern Medicine scientists have uncovered new details about how poxvirus hijacks its host's protein synthesis machinery ...

WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...

The approval of the mNEXSPIKE vaccine comes less than a week after Health and Human Services Secretary, Robert F. Kennedy Jr. announced the COVID vaccine for healthy children and healthy pregnant ...

Bloomberg reported that the FDA recently granted Moderna Inc. (NASDAQ:MRNA) a narrower approval for its next-generation COVID ...

With Donald Trump’s second administration, disruptive news seems to arise on a daily basis. Most concerning for clinicians ...

Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...

Moderna's (MRNA) new COVID vaccine approval targets a broader high-risk population. Check out why I see potential for a 25-40 ...